author-photo

T. Prebet

Johns Hopkins University

26

Papers

287

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

A Validation of a Post-Hypomethylating Agent Failure (HMAF) Prognostic Model in MDS Patients Treated with Rigosertib Versus Best Supportive Care (BSC)

2017 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
A phase I study of the anti-natural killer inhibitory receptor (KIR) monoclonal antibody (1–7F9, IPH2101) in elderly patients with acute myeloid leukemia (AML)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

2015 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (8)
French consensus on myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia: diagnosis, classification and treatment

2015
Show All
- Source
- Cite
- Save
Citations (0)
Consensus français sur les syndromes myélodysplasiques et la leucémie myélomonocytaire chronique : diagnostic, classifications, traitement

2015
Show All
- Source
- Cite
- Save
Citations (1)
Development of Epigenetic Targeted Therapies in Hematological Malignancies

2015
- T. Prebet
- Steven D. Gore
Show All
- Source
- Cite
- Save
Citations (0)
Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure

2013 Haematologica
Show All
- Source
- Cite
- Save
Citations (26)
P-281 Escalating doses of clofarabine (CLO) for high-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia post-MDS (sAML) failing azacitidine (AZA)

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
O-017 A Phase I/II trial of erlotinib (ERLO) in higher-risk MDS after azacitidine (AZA) failure

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)